Herbal Help for Inflammatory Bowel Disease
Crohn's disease and ulcerative colitis are both forms of inflammatory bowel disease (IBD). The conditions are chronic, and patients suffer from recurrent bouts of discomfort and even painful symptoms. Clinical and animal studies suggest turmeric and its curcumin compounds could help safely relieve symptoms and reduce relapse rates for patients with IBD. (vii.131, 158-159)
What Are the Similarities and Differences Between Crohn's Disease and Ulcerative Colitis?
Both conditions share symptoms in common, including: (vii.158)
- Abdominal pain and cramping.
- Blood and mucus in stool.
- Increased urgency of bowel movements.
- Crohn's disease inflammation can occur anywhere in the bowel and intestines. Although it mostly affects the gastrointestinal system, Crohn's disease is actually a systemic disorder. It can involve the joints, skin, eyes, liver, kidneys, and blood.
- Ulcerative colitis inflammation occurs only in the colon and rectum.
IBD Linked to Higher Risk of Colorectal Cancer
However, there are ways to significantly reduce that risk. For example, taking substances that block inflammatory molecules decreases the risk of colorectal cancer by almost 80% in patients with IBD. Turmeric contains more than one compound that does just that. (vii.20, 49, 160)
What Are the Causes of and Risk Factors for IBD?
Doctors don't know the exact cause of IBD. However, they think that both Crohn's disease and ulcerative colitis may be caused by an overactive immune system response to microbes in the intestine. In people that are genetically susceptible, this dysfunctional immune response could occur under certain conditions: (vii.131, 161)
- The intestinal lining becomes more permeable and causes too much exposure and contact between the microbes and the immune system.
- The innate immune system fails to recognize the bacteria as part of the normal microbial environment in the gut.
|Crohn's Disease||Ulcerative Colitis|
Recent population, hospital, and clinic studies from around the world indicate that in highly developed northern Europe and North America Crohn's disease is now more prevalent than ulcerative colitis, while in developing areas of the world (e.g., eastern European countries and Asia) ulcerative colitis occurs more often. Despite these differences, an emerging trend everywhere is the increasing prevalence of both IBD conditions in males. This is a marked change from the past, when Crohn's disease was 30% more prevalent in women. (vii.164)